News Conference News ACC 2026 SCOUT-HCM: Mavacamten Can Benefit Teens With Obstructive HCM, Too Caitlin E. Cox March 30, 2026
News Conference News ACC 2022 Mavacamten Yields Stable Benefits in Obstructive HCM Over Longer Term Shelley Wood April 03, 2022
News Conference News ACC 2022 New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More Shelley Wood April 01, 2022